Tiffany Olson

Tiffany P.
Olson is currently Director at Biotel Research LLC, Independent Director at Castle Biosciences, Inc. since 2021, Director at American Cancer Society, Inc., Simon Youth Foundation, Cardinal Health Foundation, and The Council on Radionuclides & Radiopharmaceuticals, Inc. Since 2022, Director at Education & Research Foundation For Nuclear Medicine & Mol, Independent Director at MiMedx Group, Inc. since 2024, and Partner at Trusted Health Advisors LLC since 2023.
Former roles include Chairman at Telix Pharmaceuticals Ltd. from 2025 to 2026, Director at ThermoGenesis Holdings, Inc. from 2008 to 2010, Director at Asuragen, Inc. from 2016 to 2021, Independent Director at BioTelemetry, Inc. from 2019 to 2021, Director at Little Rapids Corp., Community Health Network, Ativa Medical Corp., and Exosome Diagnostics, Inc. Vice President-Diagnostics at Eli Lilly & Co. from 2009 to 2011, President, Chief Executive & Financial Officer at Roche Diagnostics Corp.
from 1997 to 2008, Owner at Resource Consulting Services, Inc., President at NaviMed LLC from 2011 to 2013, and President-Nuclear & Precision Health Solutions at Cardinal Health, Inc. from 2013 to 2021.
Education includes undergraduate and MBA from St. Thomas University (Florida) and undergraduate studies at the University of Minnesota.